APOMORPHINE News
APOMORPHINE currently has 0 news articles, with 18 predicted indications.
This page combines the AI-predicted indications for APOMORPHINE with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
- Evidence level: L5
- Predicted indications (18):
- hereditary late onset Parkinson disease (99.0%)
- early-onset parkinsonism-intellectual disability syndrome (99.0%)
- juvenile onset Parkinson disease 19A (99.0%)
- X-linked parkinsonism-spasticity syndrome (99.0%)
- parkinsonian-pyramidal syndrome (99.0%)
- Parkinson disease (99.0%)
- atypical juvenile parkinsonism (99.0%)
- hemiparkinsonism-hemiatrophy syndrome (99.0%)
- polymicrogyria, perisylvian, with cerebellar hypoplasia and arthrogryposis (99.8%)
- congenital disorder of glycosylation with defective fucosylation (99.7%)
- retinal dystrophy with or without extraocular anomalies (99.7%)
- Charcot-Marie-Tooth disease, demyelinating, type 1G (99.7%)
- schizophrenia (99.7%)
- myopia X-linked (99.7%)
- atypical glycine encephalopathy (99.7%)
- myopia 26, X-linked, female-limited (99.6%)
- syndromic myopia (99.6%)
- hydranencephaly (disease) (99.5%)
Related News (0)
No related news yet. When news mentions this drug, it will be collected and shown here automatically.
Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.